Release Date: 16/03/12 08:29 Summary: December 2011 Half Year Financial Statements Price Sensitive: No Download Document 2.64MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%